Evidence map›Paper›PMID 31429513›Full record

ArticleJournal of veterinary internal medicine2019

Development of a comprehensive protein microarray for immunoglobulin E profiling in horses with severe asthma.

Samuel White, Meriel Moore-Colyer, Eliane Marti, Laurent Coüetil, Duncan Hannant, Eric A Richard, Marcos Alcocer

Open access · goldAbstract read
In one paragraph

Article in Journal of veterinary internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Frontiers in immunology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Microarray molecular mapping of horses with severe asthma.Journal of veterinary internal medicine
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Samuel WhiteSchool of Equine Management and Science, Royal Agricultural University, Gloucestershire, United Kingdom.ORCID https://orcid.org/0000-0002-3675-7545
Meriel Moore-ColyerSchool of Equine Management and Science, Royal Agricultural University, Gloucestershire, United Kingdom.
Eliane MartiDepartment of Clinical Research and Veterinary Public Health, University of Bern, Bern, Switzerland.
Laurent CoüetilVeterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA.ORCID https://orcid.org/0000-0002-1516-6666
Duncan HannantSchool of Veterinary Medicine and Science, University of Nottingham, Loughborough, United Kingdom.
Eric A RichardLABÉO Frank Duncombe, Caen Cedex, France.
Marcos AlcocerSchool of Biosciences, University of Nottingham, Loughborough, United Kingdom.
University of Nottingham · GBGloucestershire Royal Hospital · GBPSA Peugeot Citroën (France) · FRPurdue University West Lafayette · USUniversity of Bern · CH

Funding

Fred And Marjorie Sainsbury Charitable TrustHAYGAINThe Royal Agricultural University
6 · The paper itself

Abstract

backgroundSevere asthma in horses, known as severe equine asthma (SEA), is a prevalent, performance-limiting disease associated with increased allergen-specific immunoglobulin E (IgE) against a range of environmental aeroallergens.

objectiveTo develop a protein microarray platform to profile IgE against a range of proven and novel environmental proteins in SEA-affected horses. ANIMALS: Six SEA-affected and 6 clinically healthy Warmblood performance horses.

methodsDeveloped a protein microarray (n = 384) using protein extracts and purified proteins from a large number of families including pollen, bacteria, fungi, and arthropods associated with the horses, environment. Conditions were optimized and assessed for printing, incubation, immunolabeling, biological fluid source, concentration techniques, reproducibility, and specificity.

resultsThis method identified a number of novel allergens, while also identifying an association between SEA and pollen sensitization. Immunolabeling methods confirmed the accuracy of a commercially available mouse anti-horse IgE 3H10 source (R CONCLUSIONS AND CLINICAL IMPORTANCE: We have established that protein microarrays can be used for large-scale IgE mapping of allergens associated with the environment of horses. This technology provides a sound platform for specific diagnosis, management, and treatment of SEA.

Indexed as

AnimalsArthropodsAsthmaBronchoalveolar Lavage FluidCase-Control StudiesFungiHorse DiseasesHorsesImmunoglobulin EMicePollenProtein Array AnalysisImmunoglobulin EallergenhorseIgEprotein microarraysevere equine asthma

Identifiers

PMID31429513
PMCPMC6766494
OpenAlexW2969501536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.